It seems many long-term shareholders are still underwater, especially those who bought in at higher prices. I decided to invest this month just before its half-year results, anticipating a shift in the business trajectory and i got lucky to grab in low $4s. That said, the current offer seems quite low. Given the company cash balance, this offer doesn’t make much sense tbh. I decided to wind up my position today, but I really hope the rest of the shareholders see some competing bid.
Ann: Mayne Pharma enters Scheme Implementation Deed with Cosette, page-85
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.22 |
Change
0.140(2.76%) |
Mkt cap ! $424.1M | |||
| Open | High | Low | Value | Volume |
| $5.15 | $5.32 | $5.10 | $1.806M | 346.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12140 | $5.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.29 | 6600 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |